Sprycel for chronic myeloid leukemia…

March 30, 2008

Brave M, Goodman V, Kaminskas E, et al. Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate. Clin Cancer Res. 2008 Jan 15;14(2):352-9. PMID: 18223208

Describes the Food and Drug Administration review of dasatinib for CML and Ph(+) ALL.

Technorati tags:
oncology cancer chronic myeloid leukemia acute lymphoblastic leukemia

Comments and Links Appreciated.

Comments »

The URI to TrackBack this entry is: http://oncologywatch.blogsome.com/2008/03/30/sprycel-for-chronic-myeloid-leukemia/trackback/

No comments yet.

RSS feed for comments on this post.

Leave a comment

Line and paragraph breaks automatic, e-mail address never displayed, HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>



Anti-spam measure: please retype the above text into the box provided.

Get free blog up and running in minutes with Blogsome | Theme designs available here